Document Detail


Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin.
MedLine Citation:
PMID:  12429789     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There are approximately 200,000 new cases of cutaneous squamous cell carcinoma diagnosed each year in the United States, with between 1300 and 2300 deaths per year from metastatic disease. The tumor suppressor p16, encoded by the CDKN2/INK4a locus, has been reported mutated in >or=24% of squamous cell carcinomas. Mutations of the p16 gene have also been found in actinic keratoses, the first identifiable lesion in the continuum from normal skin to squamous cell carcinoma. We hypothesized that there may be an appreciable difference in expression of p16 between normal skin, actinic keratoses, squamous cell carcinoma in situ, and invasive squamous cell carcinoma. Ten actinic keratoses, 10 in situ squamous cell carcinomas, and 10 invasive squamous cell carcinomas were examined using the immunoperoxidase method with antigen retrieval for anti-p16(INK4a) antibody. All 10 actinic keratoses were positive for weak to moderate p16 staining in the lower third to lower half of the epidermis (especially the basal keratinocytes). This staining was significant when compared with the lack of staining seen in normal skin controls. Twenty percent of in situ squamous cell carcinomas had moderate to strong staining in only the lower half to lower two thirds of the epidermis, whereas 70% of the in situ squamous cell carcinomas exhibited full-thickness p16 staining, with no staining in the dermis. Thirty percent of invasive squamous cell carcinomas had full-thickness staining of the in situ component of the lesion, and 100% of invasive squamous cell carcinomas exhibited moderate to strong staining of the invasive component of the lesion. These findings indicate correlation between the increased expression of p16 during the progression of skin from actinic keratosis to in situ squamous cell carcinoma to invasive squamous cell carcinoma. These data may lend further support to the view of the actinic keratosis as a precursor lesion to squamous cell carcinoma.
Authors:
Anissa Hodges; Bruce R Smoller
Related Documents :
15144899 - Functional expression of tweak in human hepatocellular carcinoma: possible implication ...
9813719 - A differential pcr system for the determination of ccnd1 (cyclin d1) gene amplification...
14521519 - Comparison of cell proliferation in the centre and advancing fronts of oral squamous ce...
8306659 - Suppression of human corneal epithelial proliferation with breast carcinoma immunotoxin.
15383669 - Endogenous formation of morphine in human cells.
1284199 - Squamous cell carcinomas, an immunohistochemical and ultrastructural study.
15096559 - A novel technique based on a pna hybridization probe and fret principle for quantificat...
954079 - Lack of correlation between agglutinability, the surface distribution of con a and post...
15789279 - The recombinant rat glucagon-like peptide-1 receptor, expressed in an alpha-cell line, ...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc     Volume:  15     ISSN:  0893-3952     ISO Abbreviation:  Mod. Pathol.     Publication Date:  2002 Nov 
Date Detail:
Created Date:  2002-11-13     Completed Date:  2003-04-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8806605     Medline TA:  Mod Pathol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1121-5     Citation Subset:  IM    
Affiliation:
Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Carcinoma, Squamous Cell / metabolism,  pathology*
Cyclin-Dependent Kinase Inhibitor p16 / biosynthesis*
Humans
Immunohistochemistry
Keratosis / metabolism,  pathology*
Skin / chemistry,  pathology
Skin Neoplasms / metabolism,  pathology*
Chemical
Reg. No./Substance:
0/Cyclin-Dependent Kinase Inhibitor p16

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentati...
Next Document:  Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and differential...